The Evolving Treatment Landscape in Relapsed/ Refractory Follicular Lymphoma

Scientific Interchange & Workshop | <b>The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma</b>

On September 8, 2022, OncLive® brought together physicians who treat FL to participate in a virtual workshop and discuss the treatment landscape and management of patients with relapsed/refractory (R/R) FL. The discussion was led by Krish Patel, MD; perspectives and insights on current treatment options, trial data, and other novel therapies were exchanged.